Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

S100A4 Protein in Inflammatory Bowel Disease: Results of a Single Centre Prospective Study

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11150%2F17%3A10375153" target="_blank" >RIV/00216208:11150/17:10375153 - isvavai.cz</a>

  • Nalezeny alternativní kódy

    RIV/00179906:_____/17:10375153

  • Výsledek na webu

    <a href="https://actamedica.lfhk.cuni.cz/60/3/0108/" target="_blank" >https://actamedica.lfhk.cuni.cz/60/3/0108/</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.14712/18059694.2018.2" target="_blank" >10.14712/18059694.2018.2</a>

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    S100A4 Protein in Inflammatory Bowel Disease: Results of a Single Centre Prospective Study

  • Popis výsledku v původním jazyce

    Introduction: The aim of our study was to assess association of serum S100A4 protein with ulcerative colitis (UC) and Crohn&apos;s disease (CD). Methods: Study included 118 subjects: 93 patients with CD, 16 with UC and 9 controls. In CD group, 20/93 patients had B1 phenotype, 19/93 B2, 20/93 B3 and 34/93 B2 + B3. L1 involvement was present in 15/93, L2 in 14/93 and L3 in 64/93 patients. Serum S100A4 concentration was investigated in peripheral venous blood samples by means of ELISA. Results: Serum S100A4 was significantly higher in UC (158.6 +- 56.2 ng/mL), p = 0.019 and in CD (154.4 +- 52.1 ng/mL), p = 0.007 compared to controls (104.8 +- 40.5 ng/mL). No difference in S100A4 was revealed between UC and CD, p &gt; 0.05. Serum S100A4 in each CD subgroup (according to behaviour) was significantly higher compared to controls, p &lt; 0.05. Serum S100A4 was significantly higher in L2 (144.6 +- 44.2 ng/mL), p = 0.041 and in L3 (163.0 +- 52.8 ng/mL), p = 0.002 compared to controls and in L3 compared to L1 (126.9 +- 47.6 ng/mL), p = 0.017. Conclusion: Association of serum S100A4 protein with UC and CD was confirmed. In CD, disease behaviour did not influence serum concentration of S100A4 protein. In CD, higher levels of serum S100A4 were observed in patients with ileo-colonic and colonic involvement compared to those with isolated small bowel involvement.

  • Název v anglickém jazyce

    S100A4 Protein in Inflammatory Bowel Disease: Results of a Single Centre Prospective Study

  • Popis výsledku anglicky

    Introduction: The aim of our study was to assess association of serum S100A4 protein with ulcerative colitis (UC) and Crohn&apos;s disease (CD). Methods: Study included 118 subjects: 93 patients with CD, 16 with UC and 9 controls. In CD group, 20/93 patients had B1 phenotype, 19/93 B2, 20/93 B3 and 34/93 B2 + B3. L1 involvement was present in 15/93, L2 in 14/93 and L3 in 64/93 patients. Serum S100A4 concentration was investigated in peripheral venous blood samples by means of ELISA. Results: Serum S100A4 was significantly higher in UC (158.6 +- 56.2 ng/mL), p = 0.019 and in CD (154.4 +- 52.1 ng/mL), p = 0.007 compared to controls (104.8 +- 40.5 ng/mL). No difference in S100A4 was revealed between UC and CD, p &gt; 0.05. Serum S100A4 in each CD subgroup (according to behaviour) was significantly higher compared to controls, p &lt; 0.05. Serum S100A4 was significantly higher in L2 (144.6 +- 44.2 ng/mL), p = 0.041 and in L3 (163.0 +- 52.8 ng/mL), p = 0.002 compared to controls and in L3 compared to L1 (126.9 +- 47.6 ng/mL), p = 0.017. Conclusion: Association of serum S100A4 protein with UC and CD was confirmed. In CD, disease behaviour did not influence serum concentration of S100A4 protein. In CD, higher levels of serum S100A4 were observed in patients with ileo-colonic and colonic involvement compared to those with isolated small bowel involvement.

Klasifikace

  • Druh

    J<sub>SC</sub> - Článek v periodiku v databázi SCOPUS

  • CEP obor

  • OECD FORD obor

    30219 - Gastroenterology and hepatology

Návaznosti výsledku

  • Projekt

  • Návaznosti

    S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Ostatní

  • Rok uplatnění

    2017

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název periodika

    Acta Medica (Hradec Králové)

  • ISSN

    1211-4286

  • e-ISSN

  • Svazek periodika

    60

  • Číslo periodika v rámci svazku

    3

  • Stát vydavatele periodika

    CZ - Česká republika

  • Počet stran výsledku

    6

  • Strana od-do

    108-113

  • Kód UT WoS článku

  • EID výsledku v databázi Scopus

    2-s2.0-85046283311